Career history of Eli M. Wallace
Former positions of Eli M. Wallace
| Companies | Position | Start | End |
|---|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | 31/12/1999 | 31/12/2010 |
| BRIDGEBIO PHARMA, INC. | Chief Tech/Sci/R&D Officer | 08/12/2019 | - |
| GSK PLC | Corporate Officer/Principal | - | - |
| Glaxo Wellcome Plc | Corporate Officer/Principal | - | - |
| NOVARTIS AG | Corporate Officer/Principal | - | - |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Corporate Officer/Principal | - | - |
| PELOTON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/04/2016 | - |
Training of Eli M. Wallace
| Lawrence University | Undergraduate Degree |
| Colorado State University | Doctorate Degree |
Statistics
International
| United States | 6 |
| Switzerland | 3 |
| United Kingdom | 3 |
Operational
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| NOVARTIS AG | Health Technology |
| GSK PLC | Health Technology |
| BRIDGEBIO PHARMA, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Peloton Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in translating novel scientific insights into medicines for patients with cancer and other debilitating or life-threatening conditions. Its lead drug candidate is a small molecule which targets HIF-2a, a transcription factor implicated in the development and progression of renal and other cancers. The company was founded by Steven L. McKnight in August 2010 and is headquartered in Dallas, TX. | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Health Technology |
| Glaxo Wellcome Plc | Health Technology |
- Stock Market
- Insiders
- Eli M. Wallace
- Experience